These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16198862)

  • 1. Economic effects of extended clopidogrel therapy--a word of caution.
    Eriksson P
    J Am Coll Cardiol; 2005 Oct; 46(7):1376; author reply 1376-7. PubMed ID: 16198862
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Falcone EL; Tangri N
    JAMA; 2007 Apr; 297(16):1770; author reply 1770-1. PubMed ID: 17456815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].
    Baralis G; Steffenino G; Dellavalle A; La Scala E; Uslenghi E
    Ital Heart J Suppl; 2003 Sep; 4(9):766-70. PubMed ID: 14635395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we making efficient use of clopidogrel?
    Kastrati A; Schömig A; Schömig E
    Eur Heart J; 2004 Mar; 25(6):454-6. PubMed ID: 15039123
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet therapy for ischemic heart disease.
    Steimle AE
    N Engl J Med; 2004 May; 350(20):2101-2; author reply 2101-2. PubMed ID: 15141055
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel in acute coronary syndromes: can the cost effectiveness improve?
    Sánchez-Delgado E
    Circulation; 2003 Aug; 108(8):e56; author reply e56. PubMed ID: 12939246
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Yaes RJ
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572584
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal antiplatelet treatment for percutaneous coronary intervention: clopidogrel vs. ticlopidine.
    Almsherqi ZA; McLachlan CS; Mossop P; Deng Y
    Int J Cardiol; 2007 Jan; 114(1):101-2. PubMed ID: 16343664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes.
    Heptinstall S
    J Thromb Haemost; 2006 Mar; 4(3):539-41. PubMed ID: 16405519
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Akinlade BK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12571267
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    de Lemos JA; McGuire DK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572580
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Armstrong EC
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572582
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-eluting versus bare-metal stents: when and for whom?
    Beyar R; Nikolsky E
    J Invasive Cardiol; 2008 Mar; 20(3):105-6. PubMed ID: 18316824
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Ramsey SD
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572583
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
    Tricoci P; Harrington RA; Valgimigli M
    Circulation; 2005 Oct; 112(17):e282; author reply e283. PubMed ID: 16246954
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention.
    Heeg BM; Peters RJ; Botteman M; van Hout BA
    Pharmacoeconomics; 2007; 25(9):769-82. PubMed ID: 17803335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
    Asplund K
    Lakartidningen; 2000 Mar; 97(11):1294-6. PubMed ID: 10771550
    [No Abstract]   [Full Text] [Related]  

  • 19. Tackling the diabetic platelet: is high clopidogrel dosing the answer?
    Angiolillo DJ
    J Thromb Haemost; 2006 Dec; 4(12):2563-5. PubMed ID: 16968328
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of bleeding in acute coronary syndromes with clopidogrel and prasugrel.
    Rodriguez L; Conde D; Lalor N; Elissamburu P; Trivi M
    Am J Emerg Med; 2013 Aug; 31(8):1287. PubMed ID: 23769852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.